Predict your next investment

Corporation
stdmed.com

See what CB Insights has to offer

Investments

1

About STD Med

STD Med is a provider in the development and manufacture of medical devices and precision machined components. Established in 1953, STD Med is a privately held company with facilities in Massachusetts which are ISO 13485:2003, ISO 9001:2008, JPAL and FDA approved. Over the past several years STD Med has incubated and invested in several new technologies including Angiolink Corporation (acquired by Medtronic), Arthrosurface Spirus Medical(acquired by Olympus) and Cardiosolutions and it is the company's intention to continue to pursue disruptive innovation in the medical device marketplace.

STD Med Headquarter Location

75 Mill Street PO Box 420

Stoughton, Massachusetts, 02072,

United States

781-828-4400

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Latest STD Med News

STD Med, Inc. welcomes G.I. Windows to its West Bridgewater Innovation Center

Mar 17, 2014

Windows to its West Bridgewater Innovation Center WEST BRIDGEWATER, Mass., March 17, 2014 /PRNewswire/ -- STD Med, Inc. is pleased to announce that medical device start-up company G.I. Windows, Inc. has commenced operations at our Innovation Center in West Bridgewater. Getting medical technologies to market is always a challenging endeavor; however STD Med through its Innovation Center is offering another option for start-up companies. STD Med is a 60 year-old contract manufacturing company which has reinvented itself as a multifaceted resource that med-tech entrepreneurs can utilize to cost effectively move their companies forward. "We are pleased to have GI Windows join us in our West Bridgewater incubator to advance its novel technology," said Steve Tallarida, President and CEO, STD Med, Inc. In addition to providing office and wet lab space, contract design and manufacturing as well as financial and administrative services, STD joins a strategic group of investors by making a minority investment in G.I. Window's Convertible Debt Offering. "Starting, funding and managing new technology companies is never easy and we hope our experience with our other medical device start-ups, Angiolink, Arthrosurface, Spirus Medical, Cardiosolutions and Saphena Medical will make us a valuable resource for G.I. Windows," said Andrea Patisteas, Senior Executive Vice President at STD Med. "We are delighted to be working with STD Med as we launch this exciting new company," said James Wright, President and CEO of GI Windows, "STD has a proven track record, helping young companies get started and mature to successful ventures. We have high confidence that their team, working with the group from GI Windows, will enable the company to complete the next phase of its development and future commercialization. " About STD Med, Inc. STD Med, Inc. is a rapidly growing and emerging leader in the development and manufacture of medical devices and precision machined components. Established in 1953, STD Med, Inc. is a privately held company with 3 facilities in Massachusetts which are ISO 13485:2003, ISO 9001:2008, JPAL and FDA approved. Over the past several years STD Med, Inc. has incubated and invested in several new technologies including Angiolink Corporation (acquired by Medtronic), Arthrosurface Inc. , Spirus Medical, Inc.  (acquired by Olympus), Cardiosolutions, Inc. and Saphena Medical, Inc. and it is our intention to continue to pursue disruptive innovation in the medical device marketplace. Contact: Ross Garofalo 781-828-4400 rgarofalo@stdmed.com About G.I. Windows, Inc. GI Windows is an early-stage medical device company developing a non-surgical approach to create anastomoses in the GI tract. Their technology is designed to enable a durable, intestinal bypass to address chronic diseases, such as Type-2 Diabetes and Obesity, without the cost and invasiveness of surgical interventions. Contact: James Wright, 781-436-4375 ext.1601 james.wright@giwindows.com    

STD Med Investments

1 Investments

STD Med has made 1 investments. Their latest investment was in Saphena Medical as part of their Series A on February 2, 2013.

CBI Logo

STD Med Investments Activity

investments chart

Date

Round

Company

Amount

New?

Co-Investors

Sources

2/15/2013

Series A

Saphena Medical

$3M

Yes

2

Date

2/15/2013

Round

Series A

Company

Saphena Medical

Amount

$3M

New?

Yes

Co-Investors

Sources

2

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.